Blood CD62L low inflammatory eosinophils are related to the severity of asthma and reduced by mepolizumab.

Alessandra VultaggioMatteo AccinnoEmanuele VivarelliValentina MecheriGiandomenico MaggioreLorenzo CosmiPaola ParronchiOlivero RossiEnrico Maggi Oreste Gallo Andrea Matucci

Published in: Allergy (2023)

iEos and the baseline clinical features of SEA with CRSwNP was shown. Furthermore mepolizumab restores the healthy balance among eosinophils sub-phenotypes in SEA patients.

Keyphrases

end stage renal disease
ejection fraction
chronic kidney disease
newly diagnosed
oxidative stress
prognostic factors
lung function
allergic rhinitis
drug induced